We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sharp Increase in Benign Tertian Malaria Observed in Migrants

By LabMedica International staff writers
Posted on 29 Jun 2016
Since 2014, the number of reported malaria cases of malaria in Europe have almost doubled compared to the previous years and clinicians are observing growing numbers of Plasmodium vivax infections, predominantly in refugees from Eritrea.

Plasmodium vivax infections are characterized by relapses of malaria due to persistent liver stages of the parasite called hypnozoites and those relapses can be prevented currently only by 8-aminoquinoline anti-malarial drugs, such as primaquine.

Scientists at the University Medical Centre Hamburg-Eppendorf (Hamburg, Germany) retrospectively identified all patients with P. More...
vivax malaria admitted to the University Medical Centre from 2011 until August 2015 by the hospital coding system and data was matched with records from the laboratory diagnostics unit of the Bernhard Nocht Institute for Tropical Medicine (Hamburg, Germany).

Of the 37 Eritrean patients seen in the institution since 2014, 34 were male (92 %), median age was 19 years (range 12–37 years), and 35 % (13 patients) were younger than 18 years. One patient had a mixed infection with P. falciparum. One additional case, not included in the following statistics, had an infection with Plasmodium ovale. For 35 out of the 37 P. vivax patients, the date of arrival to Germany was known. Of those, all had arrived to Germany during the previous six months (median two weeks, range 1–180 days).

The authors concluded that countries hosting Eritrean refugees need to be aware of vivax malaria occurring in this group and the risk of autochthonous cases due to local transmission by indigenous, vector competent Anopheles species. Awareness of possible P. vivax infection in this group of patients and correct diagnosis is of major importance in order to treat the patients effectively by successive primaquine administration. The study was published on June 17, 2016, in the Malaria Journal.

Related Links:
University Medical Centre Hamburg-Eppendorf
Bernhard Nocht Institute for Tropical Medicine

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.